Did STAB stock beat earnings estimates in the most recent quarter?
STATERA BIOPHARMA INC (STAB) missed EPS estimates and missed revenue estimates in the most recent quarter.
NASDAQ:STAB • US8575611046
Past quarterly earnings results for STATERA BIOPHARMA INC (STAB), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2022 | - | - | 670.47K | - | 183.47% | |||
| Q2 2022 | - | - | 768.83K | - | - | |||
| Q1 2022 | - | - | 997.84K | - | - | |||
| Q4 2021 | - | - | 1.251M | - | - | |||
| Q3 2021 | -0.47 | - | - | 236.52K | - | 441.86% | ||
| Q2 2021 | - | - | - | -100.00% | ||||
| Q1 2021 | - | - | - | - | ||||
| Q4 2020 | - | - | - | - | ||||
| Q3 2020 | - | - | 43.65K | - | - | |||
| Q2 2020 | - | - | 63.26K | - | - |
Notes
STATERA BIOPHARMA INC (STAB) missed EPS estimates and missed revenue estimates in the most recent quarter.